No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Express News | Kymera Therapeutics Inc : Btig Initiates Coverage With Buy Rating; Target Price $60
Kymera Therapeutics Initiated at Market Perform by BMO Capital
BMO Capital Initiates Kymera Therapeutics(KYMR.US) With Hold Rating, Announces Target Price $55
Cautious Optimism for Kymera Therapeutics: Hold Rating Amid Uncertainties in Innovative Protein Degradation Programs
Kymera International Acquires Coating Center Castrop GmbH
Kymera Therapeutics Raised to Overweight From Equal-Weight by Wells Fargo
Unlock the Full List